Recent successes and noteworthy future prospects in the treatment of chronic hepatitis C.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Volumn 55 Suppl 1, Issue , 2012, Pages

  Fox, Alyson N ^a   Jacobson, Ira M ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CYCLOPHILIN; DRUG DERIVATIVE; MICRORNA; N (3 AMINO 1 (CYCLOBUTYLMETHYL) 2,3 DIOXOPROPYL) 3 (2 ((((1,1 DIMETHYLETHYL)AMINO)CARBONYL)AMINO) 3,3 DIMETHYL 1 OXOBUTYL) 6,6 DIMETHYL 3 AZABICYCLO(3.1.0)HEXAN 2 CARBOXAMIDE; N-(3-AMINO-1-(CYCLOBUTYLMETHYL)-2,3-DIOXOPROPYL)-3-(2-((((1,1-DIMETHYLETHYL)AMINO)CARBONYL)AMINO)-3,3-DIMETHYL-1-OXOBUTYL)-6,6-DIMETHYL-3-AZABICYCLO(3.1.0)HEXAN-2-CARBOXAMIDE; NS 5 PROTEIN, HEPATITIS C VIRUS; NS-5 PROTEIN, HEPATITIS C VIRUS; OLIGOPEPTIDE; PROLINE; PROTEINASE INHIBITOR; TELAPREVIR; VIRUS PROTEIN;

ARTICLE; CLINICAL TRIAL (TOPIC); DRUG ANTAGONISM; DRUG COMBINATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; PATHOGENICITY; PHYSIOLOGY; TREATMENT OUTCOME; VIROLOGY; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CLINICAL TRIALS AS TOPIC; CYCLOPHILINS; DRUG THERAPY, COMBINATION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MICRORNAS; OLIGOPEPTIDES; PROLINE; PROTEASE INHIBITORS; TREATMENT OUTCOME; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 84867307862     PISSN: None     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis391     Document Type: Article

References (0)